Comparison of social distribution of immunisation with measles, mumps, and rubella vaccine, England, 1991-2001.
نویسندگان
چکیده
Since the late 1990s, the possible adverse effects of the combined measles, mumps, and rubella (MMR) vaccine have caused intense public debate. After the vaccine was introduced in 1988, coverage was high, increasing from 80% in 1989 to 92% in 1997. After 1997 coverage began to decline, and by 2001 had fallen by 4.1%, which gave some cause for concern. We examined the extent to which these trends reflect different patterns of uptake in affluent and deprived areas and changes in the equitable coverage of immunisation for MMR.
منابع مشابه
Idiopathic thrombocytopenic purpura and MMR vaccine.
A CAUSAL ASSOCIATION BETWEEN MEASLES: mumps-rubella (MMR) vaccine and idiopathic thrombocytopenic purpura (ITP) was confirmed using immunisation/hospital admission record linkage. The absolute risk within six weeks of immunisation was 1 in 22 300 doses, with two of every three cases occurring in the six week post-immunisation period being caused by MMR. Children with ITP before MMR had no vacci...
متن کاملRubella surveillance to december 1990: a joint report from the PHLS and National Congenital Rubella Surveillance Programme.
Introduction Rubella immunisation was introduced in the UK in 1970 with the aim of preventing congenital rubella syndrome (CRS) by the selective vaccination of schoolgirls and susceptible adult women. An augmented immunisation policy, aimed at eliminating circulating rubella by the mass vaccination of children of both sexes, was adopted in October 1988 with the introduction of the combined meas...
متن کاملSurveillance of congenital rubella in Great Britain, 1971-96.
Before rubella vaccine was introduced for schoolgirls and susceptible women in 1970, 200-300 babies were born annually in England and Wales with congenital defects associated with maternal rubella. In 1988 the combined measles, mumps, and rubella vaccine was introduced for all 1 year olds; in 1994, to help avert a predicted measles epidemic, all 5-16 year olds were offered combined measles and ...
متن کاملSerological evaluation of a measles, mumps, and rubella vaccine.
Combined measles, mumps, and rubella vaccination is soon to become available in Britain in the routine immunisation programme. A controlled study was performed in 319 children, aged 13 months, to assess the antibody response and clinical reactions to a new combined measles, mumps, and rubella vaccine in comparison with a single component measles vaccine. In the children who received the combine...
متن کاملCongenital rubella prevention in Singapore: a success story
The immunisation programme for rubella in Singapore started in 1976 with mass immunisation of female primary school leavers (> 11 years)1. This was extended to include male primary school leavers and national servicemen in 1982. In 1990, the trivalent MMR (measles, mumps, rubella) vaccine was introduced to children at 1 year of age. The monovalent rubella vaccine given to primary school leavers...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- BMJ
دوره 326 7394 شماره
صفحات -
تاریخ انتشار 2003